Industry Leaders Debate Big Pharma R&D (Too Little Hope?) and Stem Cell Research (Too Much hype?)
Different points on the research spectrum were under the microscope at the Wharton Health Care Business Conference last month as two panels of biotech, pharmaceutical and investment leaders discussed the state of R&D among big pharmaceuticals and the progress of stem cell research. While disappo...
Saved in:
Main Author: | Knowledge@SMU |
---|---|
Format: | text |
Language: | English |
Published: |
Institutional Knowledge at Singapore Management University
2006
|
Subjects: | |
Online Access: | https://ink.library.smu.edu.sg/ksmu/98 https://ink.library.smu.edu.sg/cgi/viewcontent.cgi?article=1097&context=ksmu |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Singapore Management University |
Language: | English |
Similar Items
-
Equity in commerce: Too much and too little?
by: YIP, Man
Published: (2023) -
Equity in commerce: Too much and too little?
by: YIP, Man
Published: (2023) -
Earning Too Little And Worrying Too Much: The Role Of Income And Financial Worries On Parents’ Well-Being In Hong Kong And Bangkok
by: Gao X.
Published: (2023) -
Continental Philosophy Today: Too Much Destruction, or Too Little?
by: Rumble, Vanessa
Published: (2024) -
Too Little or Too Much? Untangling the Relationship between Corporate Philanthropy and Corporate Financial Performance
by: WANG, Heli, et al.
Published: (2008)